195 related articles for article (PubMed ID: 14722349)
21. Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety.
Durrani K; Papaliodis GN; Foster CS
Ophthalmology; 2004 May; 111(5):960-5. PubMed ID: 15121375
[TBL] [Abstract][Full Text] [Related]
22. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
Huber AM; Feldman BM; Rennebohm RM; Hicks JE; Lindsley CB; Perez MD; Zemel LS; Wallace CA; Ballinger SH; Passo MH; Reed AM; Summers RM; White PH; Katona IM; Miller FW; Lachenbruch PA; Rider LG;
Arthritis Rheum; 2004 May; 50(5):1595-603. PubMed ID: 15146430
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis.
Nagappa M; Taly AB; Sinha S; Gayathri N; Bindu PS; Mahadevan A; Yasha T
J Clin Neuromuscul Dis; 2013 Jun; 14(4):161-8. PubMed ID: 23703010
[TBL] [Abstract][Full Text] [Related]
24. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
Ang GC; Werth VP
Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
26. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Gladstone DE; Zamkoff KW; Krupp L; Peyster R; Sibony P; Christodoulou C; Locher E; Coyle PK
Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
[TBL] [Abstract][Full Text] [Related]
27. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
de Seze J; Delalande S; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Hatron PY; Vermersch P
J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
[TBL] [Abstract][Full Text] [Related]
28. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
29. Intravenous cyclophosphamide for lupus nephritis in Thai children.
Vachvanichsanong P; Dissaneewate P; Winn T
Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
[TBL] [Abstract][Full Text] [Related]
30. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
Boogaard R; Drexhage VR; van Suijlekom-Smit LW
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):146-50. PubMed ID: 15693592
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
[TBL] [Abstract][Full Text] [Related]
33. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
34. Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.
Valentini G; Paone C; La Montagna G; Chiarolanza I; Menegozzo M; Colutta E; Ruocco L
Scand J Rheumatol; 2006; 35(1):35-8. PubMed ID: 16467039
[TBL] [Abstract][Full Text] [Related]
35. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
36. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and disease course of patients with juvenile dermatomyositis.
Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
[TBL] [Abstract][Full Text] [Related]
38. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
[TBL] [Abstract][Full Text] [Related]
39. High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy.
Gladstone DE; Prestrud AA; Brannagan TH
J Peripher Nerv Syst; 2005 Mar; 10(1):11-6. PubMed ID: 15703014
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
